Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3Thoracic 1Sarcoma 1Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Hematologic Neoplasms 1

Interventions

venetoclax 307Cyclophosphamide 234Cytarabine 202Azacitidine 190fludarabine 183Specimen Handling 136Biopsy 103fludarabine phosphate 98Methotrexate 83Rituximab 79Daunorubicin 78Dexamethasone 77Vincristine 70Whole-Body Irradiation 65Mycophenolic Acid 60Decitabine 58Tacrolimus 56Etoposide 53ibrutinib 52blinatumomab 52obinutuzumab 51Granulocyte Colony-Stimulating Factor 51Busulfan 50Prednisone 48Melphalan 48acalabrutinib 47Injections 47Stem Cell Transplantation 45Idarubicin 45Magnetic Resonance Spectroscopy 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Psilocybin × Other hematologic neoplasm × 1 year × Clear all
NCT05506982 2025-07-23

Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain

Emory University

Phase 1 Completed
11 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡